LUNG SHIELD

Cellular Therapy Coverage for Post Covid-19 Lung Infection

Lung Shield ‘Program’ provides clients with compassionate use of cellular therapy coverage for post COVID-19 Lung Infection Recovery.

In support of the national vaccination program, all clients of Lung Shield will also be provided a complimentary post COVID-19 vaccine complication cover and accidental death benefits.

Cellular therapy is clinically proven to be effective in the field of regenerative medicine and holds promising potential in treating lung damage inflicted by Covid-19.

Lung Shield only uses stem cells produced under current Good Manufacturing Practice (cGMP).

Only RM 2.70 / Day*

Picture source: https://www.imperial.ac.uk

Program Benefits

CELLULAR COVERAGE:

  • Cellular therapy for lung damage caused by post Covid-19 infection (Up to 40 million Mesenchymal Stem Cells) 

  • Pre cellular therapy health screening

  • Lung function test 

     

    Underwritten by: The Pacific Insurance Berhad 

PERSONAL ACCIDENT INSURANCE:

  • Accidental death RM5,000

  • Accidental permanent disablement RM5,000

    Underwritten by: The Pacific Insurance Berhad 

POST COVID-19 VACCINATION COVERAGE:

  • Daily Hospital Income Benefit at RM400 per day up to RM5,600

  • A lump sum benefit of RM4,000 for Intensive Care Unit (ICU) admission

  • Bereavement expense benefit up to RM10,000

  • Accidental death RM10,000

    Underwritten by: Chubb Insurance Malaysia Berhad

SURVEILLANCE INCLUDED

  • Free initial RT-PCR Test 

  • Free Functional Neutralising Total Antibody Test  (Check your immunity levels towards Covid-19!)

    * Limited to 2 persons per family package

E&OE and T&Cs apply

The Pacific Insurance Berhad (“TPIB”) and Chubb Insurance Malaysia Berhad (“Chubb”) are licensed under the Financial Services Act 2013 and are regulated by Bank Negara Malaysia.

Individual

RM 999
Annually
  • Per Pax
Popular

Family Client

RM 1,799
Annually
  • Husband & Wife: RM1,799.00
  • Husband, Wife & Child: RM2,399.00
  • Husband, Wife & Children: RM2,999.00
  • Single Mum/Dad & Child: RM1,799.00
  • Single Mum/Dad & Children: RM2,399.00
  • Surveillance Benefits limited up to two (2) persons per family package. Additional members of the family will be charged at the rate of RM 300 per pax

Corporate price available

Tailor-made
  • Contact Us to Find Out More

Who Can Apply

With Negative RT-PCR Test results within 48 hours prior to application (testing costs are inclusive in the program)

Open to all ages

Open to all with pre existing conditions or comorbidities (except with cancer, Lung related illness & previously Covid-19 positive)

Open to all citizens and permanent residents of Malaysia only

Vaccinated with at least one (1) dose

What is Cellular Therapy?

Cellular therapy have the ability to differentiate, repair, restore, replace and regenerate cells. It can provide new cells as the body grows and replace cells that are damaged or lost. Hence, widely known as regenerative medicine.

Cellular Therapy is less immunogenic.  It lowers the risks of rejection by the individual’s immune system and complications when transplanted.

Cellular Therapy possesses a unique homing ability. Once transplanted, the  cells are naturally directed to the damaged tissues which are in need of repair and replacement. 

CATEGORIS OF INFECTION

Post Covid-19 Lung Conditions 

Generally, patients recover within weeks from Covid-19 infection but some unfortunately experience “Post Covid-19 Lung Infection’, also known as “Long Covid” especially from the assault of the new variants and cytokines storm. 

Some may even experience conditions consisting of multiorgan effects that lasts for months after infection. 

(https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html)

How It Works:

Repair & regenerate damaged cells

Anti-inflammatory Actions

Reduces Oxidative Stress

Tissue Repair/ Renovation

Antimicrobial Action

• Repair & regenerate damaged cells

• Anti-inflammatory Actions

• Reduces Oxidative Stress

• Tissue Repair/ Renovation

• Antimicrobial Action

Cellular therapy possesses immunomodulatory properties. They have been shown to reduce inflammatory markers in several studies.

Recent Clinical Trials show that cellular therapy reduces the risk of complications and death in SARS-CoV-2 infected patients. They help to improve the microenvironment, promote neovascularisation, inhibit pulmonary fibrosis and enhance tissue repair capabilities.

Generally all stem cell products require FDA approval. Currently, the only stem cell products that are FDA-approved for use in the United States consist of blood forming stem cells also known as (hematopoietic progenitor cells) that are derived from the umbilical cord blood. These products are approved for use in patients with disorders that affect the production of blood.

In April 2020, the U.S. Food and Drug Administration (FDA) authorized a clinical trial exploratory efficacy study that used umbilical cord-derived MSCs for prevention of the life-threatening lung inflammation in COVID-19 patients.

Stem cells should only be used in FDA-approved clinical trials, expanded access program, or an Emergency Investigation New Drug application and for compassionate use.

Journals

  1. https://doi.org/10.1186/s13054-020-03142-8https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510562/
  2. https://doi.org/10.1111/cpr.12947
  3. https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.20-0472https://www.sciencedirect.com/science/article/pii/S1873506121000854
  4. http://dx.doi.org/10.14336/AD.2020.0228https://www.sciencedirect.com/science/article/pii/S1873506121000854#b0405
  5. https://pubmed.ncbi.nlm.nih.gov/33529945/
  6. https://doi.org/10.1186/s13287-021-02483-7https://www.sciencedirect.com/science/article/pii/S0753332221000858
  7. https://doi.org/10.1016/j.eclinm.2020.100454https://www.hindawi.com/journals/sci/2021/6666370/
  8. https://doi.org/10.1038/s41536-021-00147-xhttps://www.sciencedirect.com/science/article/pii/S0378111921000652#!
  9. https://doi.org/10.1101/2020.10.15.20213553https://www.nature.com/articles/s41536-020-00105-z
  10. https://doi.org/10.1186/s13287-020-01875-5https://doi.org/10.1186/s13287-020-01875-5https://www.sciencedirect.com/science/article/pii/S0378111921000652
  11. https://www.frontiersin.org/articles/10.3389/fcell.2020.627414/full

News

  1. https://www.thenationalnews.com/uae/health/uae-s-first-covid-19-patient-to-recover-after-stem-cell-therapy-tells-of-medical-journey-1.1018080
  2. https://www.channelnewsasia.com/news/singapore/family-of-covid-19-patient-appeals-to-use-stem-cell-therapy-12544048
  3. https://bioinst.com/en/covid-19-stem-cells-among-most-promising-treatments
  4. https://www.einpresswire.com/article/532284733/adult-stem-cell-therapy-for-covid-19-sequelae-begins-in-japan-for-the-first-time-in-the-world

ACT NOW

Underwriters and consultants: CHUBB Insurance Malaysia Bhd, Pacific Insurance Bhd, Howden Insurance Brokers Sdn Bhd, and ALPS Insurance PCC Inc
Frequently Asked Questions
[helpie_faq group_id=’69’/]

Contact us to Know More

+603-2181 5335
+603-2181 5445
+603-2181 5665

Be part of ALPS

A New Chapter business of saving lives

Recruiting: Agents, Distributors & Partners

From all industries

Sales Agents

Apply

© ALPS GlobeMedic Sdn Bhd 2024

Apply for success